NOVA LTD. NVMI
Nasdaq · XNAS · stock · Optical Instruments & Lenses
Chart by TradingView
4/9
Piotroski F — financial health
6.81
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $880.6M | $259.2M | $505.2M | $217.9M | $1.3B |
| 2024 | $672.4M | $183.8M | $387.1M | $218.1M | $927.8M |
| 2023 | $517.9M | $136.3M | $293.2M | $106.3M | $750.8M |
| 2022 | $570.7M | $140.2M | $317.0M | $98.2M | $587.0M |
| 2021 | $416.1M | $93.1M | $235.4M | $127.4M | $473.8M |
| 2020 | $269.4M | $47.9M | $151.2M | $53.8M | $371.5M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 6.81 (safe)
- Working capital / assets 0.503
- Retained earnings / assets 0.448
- EBIT / assets 0.107
- Equity / liabilities 1.265
Source: SEC EDGAR filings · CIK 0001109345 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.